MedTrace Logo

Fractalkine-CX3CR1 Axis in Periodontal Therapy

NCT07307144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-12-29

No results posted yet for this study

Summary

This study aimed to evaluate gingival crevicular fluid (GCF) levels of fractalkine/CX3CL1 and CX3CR1 in patients with gingivitis and periodontitis before and after non-surgical periodontal therapy.

Conditions

  • Periodontitis
  • Gingivitis
  • Inflammation Biomarkers

Interventions

OTHER

Non-surgical periodontal treatment

Scaling and root planing, oral hygiene education and motivation.

Sponsors & Collaborators

  • Giresun University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
47 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-15
Primary Completion
2023-11-15
Completion
2023-12-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07307144 on ClinicalTrials.gov